ProstaLund AB (publ) (PLUN.ST) Research

ProstaLund AB (publ) specializes in the creation and distribution of urological medical devices, primarily targeting patients with benign prostatic hyperplasia (BPH) in Sweden and across global markets. Their product offerings include CoreTherm, a thermal treatment method for BPH, and Gepan instill, designed for addressing chronic bladder inflammation. These solutions are utilized in hospitals and various clinical settings. Established in 1991, the company is based in Lund, Sweden, and operates as a subsidiary of Farstorps Gard Forvaltnings AB.

Market snapshot

Symbol
PLUN.ST
Price
$0.21
Day change
-35.15%
Market cap
$775.5K
P/E ratio
-0.33x
52-week range
0.15-11.88
Sector
Healthcare
Industry
Medical - Care Facilities

Peer companies

  • Acarix AB (publ) (ACARIX.ST)
  • Ambea AB (publ) (AMBEA.ST)
  • Attendo AB (publ) (ATT.ST)
  • IMAC Holdings, Inc. (BACK)
  • Episurf Medical AB (publ) (EPIS-B.ST)
  • Humana AB (publ) (HUM.ST)
  • SciBase Holding AB (publ) (SCIB.ST)
  • Senzime AB (publ) (SEZI.ST)

Open ProstaLund AB (publ) (PLUN.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.